Mono Pharmacare Limited
Incorporated in 1994, Mono Pharmacare Limited is engaged in the business of marketing and distribution of pharmaceutical products
What Mono files
- Others41
- Board Meeting14
- Important12
- Updates3
- Results2
- Dividend/Bonus2
MONO PHARMACARE was fined ₹96,760 by NSE for a compliance lapse. The Board noted the issue, expressed concern, and directed management to strengthen internal controls to prevent recurrence.
Mono Pharmacare received a ₹0.02 Cr fine from NSE for inadvertent non-compliance. The company implemented corrective steps. Its Board advised management to strengthen internal compliance to prevent future recurrences.
The provided text contains only a digital signature and date, with no company update, operational changes, business developments, or financial information to summarize. Please provide the company update content.
Mono Pharmacare has announced a board meeting to approve the financial results for the quarter and half-year. Their audited consolidated results show combined assets of Rs. 52.5 Cr, revenues of Rs. 100.47 Cr, and net profit after tax of Rs. 1.57 Cr for the year. IPO proceeds of Rs. 14.84...
Sure! Please provide the document or details you would like me to summarize.